Cure My Disease

Don't miss your cure!

 Log in / Sign up

New shot tested for people with unbearable seasonal allergies

NCT ID NCT03369704

Completed Symptom relief Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study tested whether adding an injectable medication called omalizumab could help people with severe Japanese cedar pollen allergies who still suffer despite using standard allergy medicines like nasal sprays and antihistamines. The 12-week trial involved 337 adults and adolescents and compared omalizumab to a placebo (dummy shot), with both groups continuing their usual allergy treatments. Researchers measured changes in symptoms like sneezing, runny nose, itchy eyes, and how much the allergies interfered with daily life.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEASONAL ALLERGIC RHINITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Novartis Investigative Site

    Chiba, Chiba, 262-0015, Japan

  • Novartis Investigative Site

    Ichikawa, Chiba, 272-0143, Japan

  • Novartis Investigative Site

    Kashiwa, Chiba, 2270082, Japan

  • Novartis Investigative Site

    Matsudo, Chiba, 270-0034, Japan

  • Novartis Investigative Site

    Matsudo, Chiba, 2710077, Japan

  • Novartis Investigative Site

    Urayasu, Chiba, 279-0012, Japan

  • Novartis Investigative Site

    Kawasaki, Kanagawa, 212-0027, Japan

  • Novartis Investigative Site

    Kawasaki, Kanagawa, 216 0006, Japan

  • Novartis Investigative Site

    Kawasaki, Kanagawa, 216-0002, Japan

  • Novartis Investigative Site

    Yokohama, Kanagawa, Japan

  • Novartis Investigative Site

    Koshigaya, Saitama, 343-0031, Japan

  • Novartis Investigative Site

    Arakawa-ku, Tokyo, 116 0011, Japan

  • Novartis Investigative Site

    Chiyoda-ku, Tokyo, 101-0063, Japan

  • Novartis Investigative Site

    Chuo Ku, Tokyo, 103 0027, Japan

  • Novartis Investigative Site

    Edogawa-ku, Tokyo, 132-0014, Japan

  • Novartis Investigative Site

    Katsushika-ku, Tokyo, 125-0061, Japan

  • Novartis Investigative Site

    Nakano-ku, Tokyo, 164-0012, Japan

  • Novartis Investigative Site

    Setagaya-ku, Tokyo, 158-0097, Japan

  • Novartis Investigative Site

    Shinjuku Ku, Tokyo, 160-0008, Japan

  • Novartis Investigative Site

    Shinjuku-ku, Tokyo, 160-0017, Japan

  • Novartis Investigative Site

    Shinjuku-ku, Tokyo, Japan

  • Novartis Investigative Site

    Toshima-Ku, Tokyo, 170-0005, Japan

Conditions

Explore the condition pages connected to this study.

SEASONAL ALLERGIC RHINITIS